Stem cell therapy benefited patients with ischemic cardiomyopathy regardless … – Healio
|
Stem cell therapy benefited patients with ischemic cardiomyopathy regardless …
Healio The analysis included patients with ischemic cardiomyopathy who had received mesenchymal stem cells via transendocranial stem cell injection as part of the TAC-HFT (n=19) and POSEIDON (n=30) trials. The researchers assessed functional capacity via … |
